This inflammatory marker has also been examined in the present study, and the results showed that the expression level of IL-6 in the AD-MSCs group significantly decreased during the 3-month follow-up, indicating that AD-MSCs by immune system modulation alleviated the inflammation triggered by KOA. This evidence concerns the gene IL6 and Alzheimer disease.